Bayer's $2B Deal May Not Spell The End For Roundup
Bayer's proposed deal on Wednesday to settle future cancer claims in long-running litigation over its Roundup weedkiller may have an eye-popping $2 billion price tag, but experts say the settlement may...To view the full article, register now.
Already a subscriber? Click here to view full article